United Therapeutics
UTHR
#1021
Rank
C$30.73 B
Marketcap
C$679.57
Share price
-1.33%
Change (1 day)
32.42%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): C$40.10

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$39.05. In 2024 the company made an earnings per share (EPS) of C$36.23 an increase over its 2023 EPS that were of C$28.84.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$40.1010.7%
2024C$36.2325.59%
2023C$28.8431.54%
2022C$21.9351.18%
2021C$14.50-9.1%
2020C$15.96-581.4%
2019C-$3.31-117.79%
2018C$18.6342.11%
2017C$13.11-40.93%
2016C$22.1913.45%
2015C$19.56104.29%
2014C$9.57100.29%
2013C$4.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
C$28.10-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$8.93-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.86-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
C$2.36-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$0.90-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$8.61-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.92-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
C$9.12-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA